+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts



Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts



American Journal of Pathology 147(2): 461-475



In heart transplantation, long-term engraftment success is severely limited by the rapid development of obliterative disease of the coronary arteries. Data from various groups have been suggestive of a pathogenetic role of herpesviruses, particularly human cytomegalovirus, in accelerated allograft coronary artery disease; however, results are not yet conclusive. This study examines the hypothesis that human cytomegalovirus infection of allograft tissues is related pathogenetically and directly to accelerated coronary artery disease. Using in situ DNA hybridization and polymerase chain reaction, we examined particular coronary artery segments from 41 human heart allografts (ranging from 4 days to greater than 4 years after transplantation; mean, 457 days) and 22 donor age- and gender-comparable, coronary site-matched trauma victims for presence of human cytomegalovirus DNA. Human cytomegalovirus genome was detected in 8 of 41 (19. 5%) allografts and in 1 of 22 (4.5%) control hearts. This difference in positivity was not statistically significant (P = 0.10). In the human cytomegalovirus-positive hearts, viral genome was localized to perivascular myocardium or coronary artery media or adventitia. Human cytomegalovirus genome was not detected in arterial intima of any allograft or control heart, although human cytomegalovirus genome was readily identified within intima of small pulmonary arteries from lung tissue with human cytomegalovirus pneumonitis. By statistical analyses, the presence of human cytomegalovirus genome was not associated with the nature or digitized extent of transplant arteriopathy, evidence of rejection, allograft recipient or donor serological data suggestive of human cytomegalovirus infection, duration of allograft implantation, or causes of death or retransplantation. Thus, our data indicate a low frequency of detectable human cytomegalovirus genome in accelerated coronary artery disease and do not support a direct role for human cytomegalovirus in vascular wall infection or in the development of accelerated coronary artery disease.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008873611

Download citation: RISBibTeXText

PMID: 7639338


Related references

Molecular evaluation of a direct role for cytomegalovirus in coronary arteriopathy of human heart allografts. Circulation 88(4 Part 2): I482, 1993

Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. Journal of Heart Transplantation 9(4): 364-371, 1990

Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. American Journal of Pathology 147(2): 293-308, 1995

Human cytomegalovirus immediate-early protein IE2-86, but not IE1-72, causes graft coronary arteriopathy in the transplanted rat heart. Circulation 106(12 Suppl 1): I158-I162, 2002

Human cytomegalovirus immediate-early protein IE2, but not IE1, causes graft coronary arteriopathy in the transplanted rat heart. Circulation 104(17 Suppl.): II 758, 2001

Distinctive localization of biglycan, decorin and versican in epicardial coronary arteries of human heart allografts Clues to arteriopathy. Journal of Heart & Lung Transplantation 14(1 Part 2): S44, 1995

Cytomegalovirus and other herpesviruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts?. Journal of Heart and Lung Transplantation 11(3 Pt 2): S14-S20, 1992

Comparable proximal and distal severity of intimal thickening and size of epicardial coronary arteries in transplant arteriopathy of human cardiac allografts. Journal of Heart and Lung Transplantation 13(5): 824-833, 1994

Lack of evidence for greater distal severity of accelerated intimal proliferation in transplant arteriopathy of human heart allografts Histomorphometric documentation. Circulation 86(4 Suppl. 1): I36, 1992

Cytomegalovirus infection-associated immune activation in human blood and heart allografts. Transplantation Proceedings 26(3): 1721-1722, 1994

The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. Transplantation 56(5): 1103-1108, 1993

Key histopathological features and clues to the pathogenesis of allograft arteriopathy Studies of epicardial coronary arteries from 41 cardiac allografts. Laboratory Investigation 68(1): 26A, 1993

Immunoreactivity of monoclonal antibody to cytomegalovirus in coronary atherosclerosis and transplant arteriopathy. Laboratory Investigation 64(1): 19A, 1991

Arteriopathy in human cardiac allografts an immunopathology study. Laboratory Investigation 64(1): 20A, 1991

Obliterative arteriopathy in chronic rejection after hepatic transplantation. Search of cytomegalovirus genome by in situ hybridization and viral antigens by immunohistochemistry. Gastroenterologie Clinique et Biologique 21(4): 259-264, 1997